Clot removal success factors revealed in large stroke study

NCT ID NCT06016348

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at 400 stroke patients who had a clot-removal procedure (thrombectomy) within 24 hours of symptoms. Researchers wanted to find out which factors helped patients recover well, such as being able to walk independently. The goal is to better predict who benefits from this treatment, even when the stroke damage is large.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors identify which stroke patients are most likely to benefit from clot removal, even when the damage is large.

What could go wrong

This is an observational study, not a treatment trial. It only looks for patterns in past outcomes, so it cannot prove what works best for future patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 115 PEOPLE's HOSPITAL

    Ho Chi Minh City, 70000, Vietnam

  • Can Tho Central General Hospital

    Can Tho, Vietnam

  • Da Nang Stroke Center

    Da Nang, Vietnam

  • University Medical Center

    Ho Chi Minh City, 70000, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.